News · Longevity & Aging
Long COVID fatigue improved across a whole trial, while whole-body MRI and app rehab added nothing
Long COVID clinics have been built without much evidence about what inside them works. A trial across 122 primary care networks tested two additions against ordinary multidisciplinary care.
- Fatigue scores improved by about 4.5 points in every arm over 12 weeks.
- Adding multi-organ MRI made no measurable difference against usual care.
- A digital rehabilitation program made no measurable difference either.
- No serious adverse events were linked to the pathway interventions.
- 1,152 participants across 122 randomized networks, with no untreated comparison group.
Long COVID clinics were built quickly, under pressure, for a condition nobody understood. What went inside them was assembled from plausible ideas rather than from trials, because there were no trials.
That leaves an awkward question once the clinics exist. Not whether to treat people, but which of the things being done to them is doing anything.
How 122 care networks were randomized
Writing in Nature Medicine, researchers randomized 122 primary care networks rather than individual patients, so that each area delivered one version of care as standard.
Every network ran an integrated care pathway. On top of that, some added a scan of several organs at once, some added a digital rehabilitation program, some added both, and some added neither. Previously no trial had separated the components of a Long COVID pathway from one another.
1,152 participants consented, and the main measure was a fatigue questionnaire at twelve weeks.
How far Long COVID fatigue fell in every arm
Fatigue improved. Scores fell by about four and a half points across the trial, which is a meaningful shift on that scale for people who had been ill for months.
What multi-organ MRI added to the pathway
Nothing measurable.
Against usual care, the multi-organ scan produced a difference of about two tenths of a point on the fatigue scale. The digital rehabilitation program produced about half a point. Their combination produced about two tenths.
All three estimates sit comfortably within the range you would expect from chance, and none approaches the size of the improvement everyone got anyway.
Why the Long COVID scan result matters most
Multi-organ imaging is expensive, and it is being sold privately to people with Long COVID who are desperate for an explanation.
The reasoning behind it was decent: the condition has been linked to abnormalities in heart, lungs, liver and kidneys, so a scan covering all of them might direct treatment. This trial tested whether that directed treatment left people less exhausted, and it did not.
The authors put it carefully. Multidisciplinary holistic clinical care is associated with fatigue reduction in Long COVID, irrespective of multi-organ MRI. The care helps; the scanning on top of it does not appear to.
What this Long COVID trial cannot establish
There was no group that received nothing, so the improvement everyone experienced cannot be attributed to the pathway with confidence. Fatigue is a condition that improves for many people over months, and questionnaire scores drift toward the middle on repeat measurement regardless.
Twelve weeks is also short for a condition measured in years, and the secondary assessment at twenty-four weeks does not change the picture. The authors note that digital rehabilitation could be useful in longer-term management, which is a hypothesis rather than a result.
Where this leaves people living with Long COVID
Fatigue is a feeling of weariness, tiredness, or lack of energy that does not improve with rest, and Long COVID produces it in a form that has resisted almost everything tried against it.
The honest reading of this trial is unsatisfying and useful. Organized multidisciplinary care is where the evidence sits. The expensive addition tested here did not improve how people felt, which is worth knowing before anyone pays for it privately.
People also ask
What did the trial find?
Among 1,152 participants across 122 clusters, baseline Fatigue Assessment Scale score was 35.8 and improved by 4.5 points to 31.3 at 12 weeks across all arms. Compared with usual care, effects on 12-week scores were -0.18 (95% CI -0.72 to 1.09; P = 0.69) with multi-organ MRI, -0.53 (-1.42 to 0.36; P = 0.25) with digital rehabilitation and -0.17 (-1.06 to 0.72; P = 0.71) for their interaction.
What is an integrated care pathway?
A defined route through the health system for a condition, setting out who assesses the patient, what is checked and who they are referred to. For Long COVID it usually means a multidisciplinary clinic rather than a single specialist.
What was the multi-organ MRI for?
Long COVID has been linked to abnormalities across several organs, and the hypothesis was that scanning heart, lungs, liver and kidneys together would direct care more precisely. The trial tested whether that changed how people felt.
Does this mean the scans found nothing?
It means adding them did not improve fatigue at 12 weeks compared with the pathway alone. That is a different claim from saying the scans detect nothing, and the trial does not test their diagnostic value in isolation.
Why did everyone improve if nothing worked?
Everyone received the integrated care pathway, so the arms differ only in the additions. Improvement across all arms is consistent with the pathway itself helping, and also with natural recovery and regression to the mean, which this design cannot separate.
Why is there no untreated group?
Withholding care from people with a disabling condition to create one raises its own problems, and the trial was designed to compare additions rather than to prove the pathway works. That is the main limit on what it can conclude.
What should someone with Long COVID take from this?
That multidisciplinary clinical care is where the evidence currently sits, and that paying for extensive private scanning is not supported by this trial. Care decisions belong with a clinician. This is general information rather than medical advice.